Testing effectiveness (Phase 2)Study completedNCT01359969
What this trial is testing
Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients
Who this might be right for
Hereditary Angioedema
Pharming Technologies B.V. 57
Showing 20 of 0 results